Effect of Goserelin (Zoladex®) in Spinal and Bulbar Muscular Atrophy

Summary

This is a therapeutic trial study to demonstrate whether Goserelin, a LHRH agonist has benefit in SBMA Objective: 1. To study effects of Goserelin to clinical course of patients with spinal and bulbar muscular atrophy in Thailand 2. To demonstrate physiological and pathological changes in treated patients with Goserelin. 3. To assess tolerability and adverse effect of Goserelin therapy

Timeline

Start

2008-04

Primary completion

2011-11

Completion

2013-11

Drugs

Indications